Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 6, 2010
Grant Date -
May 15, 2008
app pub date -
Aug 30, 2007
filing date -
Mar 11, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A novel method for immunosuppressive in a mammal suffering from an immune disease, including administering to the mammal a therapeutically effective amount of a heterocyclic compound represented by the general formula (I) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is disclosed. A novel heterocyclic compound represented by the general formula (II) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is also disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully